[{"AccountsPayableCurrent_0_Q2_USD":12052000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_2_Q2_USD":323000.0,"WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_2_Q2_shares":1633462.0,"WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_1_Q2_shares":1596317.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":693000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":3980000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":7932000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":4470000.0,"OtherLiabilitiesCurrent_0_Q2_USD":1463000.0,"IncreaseDecreaseInContractWithCustomerLiability_2_Q2_USD":-3500000.0,"IncreaseDecreaseInContractWithCustomerAsset_2_Q2_USD":90000.0,"ContractWithCustomerAssetNetCurrent_0_Q2_USD":222000.0,"PaymentsToAcquireInvestments_2_Q2_USD":139689000.0,"IncomeLossFromEquityMethodInvestments_2_Q2_USD":-613000.0,"IncomeLossFromEquityMethodInvestments_1_Q2_USD":-131000.0,"AvailableForSaleSecuritiesAmortizedCost_0_Q2_USD":462329000.0,"AvailableForSaleSecurities_0_Q2_USD":462473000.0,"AvailableForSaleSecuritiesCurrent_0_Q2_USD":177288000.0,"DeferredRentCreditNoncurrent_0_Q2_USD":3439000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_2_Q2_USD":80000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q2_USD":-144000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q2_USD":-144000.0,"IncomeLossFromContinuingOperationsPerBasicAndDilutedShare_2_Q2_USD":-1.57,"IncomeLossFromContinuingOperationsPerBasicAndDilutedShare_1_Q2_USD":-0.93,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-72747000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-45218000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":4470000.0,"AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_1_Q2_USD":21629000.0,"AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q2_USD":151000.0,"AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q2_USD":7000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":1750000.0,"RestrictedCashNoncurrent_0_Q2_USD":203000.0,"ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_2_Q2_USD":0.0,"ProceedsFromSaleOfShortTermInvestments_2_Q2_USD":1003000.0,"ProceedsFromSaleMaturityAndCollectionsOfInvestments_2_Q2_USD":92134000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_2_Q2_USD":3001000.0,"InterestReceivableCurrent_0_Q2_USD":239000.0,"IncreaseDecreaseInOtherNoncurrentLiabilities_2_Q2_USD":310000.0,"IncreaseDecreaseInOtherNoncurrentAssets_2_Q2_USD":135000.0,"GainLossOnSaleOfEquityInvestments_1_Q2_USD":131000.0,"GainLossOnSaleOfEquityInvestments_2_Q2_USD":613000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_2_Q2_USD":0.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":1194000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_2_Q2_USD":0.0,"FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3_2_Q2_USD":0.0,"FairValueLiabilitiesLevel2ToLevel1TransfersAmount_0_Q2_USD":0.0,"FairValueLiabilitiesLevel1ToLevel2TransfersAmount_0_Q2_USD":0.0,"FairValueAssetsLevel2ToLevel1TransfersAmount_0_Q2_USD":0.0,"FairValueAssetsLevel1ToLevel2TransfersAmount_0_Q2_USD":0.0,"DeferredRevenueRevenueRecognized1_2_Q2_USD":3500000.0,"DeferredRevenueRevenueRecognized1_1_Q2_USD":1750000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q2_USD":8522000.0,"ContractWithCustomerLiabilityCurrent_0_Q2_USD":7000000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":227248000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q2_USD":285388000.0,"CashAndCashEquivalentsFairValueDisclosure_0_Q2_USD":285185000.0,"FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3_2_Q2_USD":0.0,"IncreaseDecreaseInAccruedLiabilities_2_Q2_USD":661000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":48053186.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":50153160.0,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":326512000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":8665000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":465000.0,"NetIncomeLoss_2_Q2_USD":-72827000.0,"NetIncomeLoss_1_Q2_USD":-45074000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-55215000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-47017000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":329480000.0,"LiabilitiesCurrent_0_Q2_USD":40025000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":481389000.0,"Liabilities_0_Q2_USD":52679000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":4601000.0,"ProfitLoss_2_Q2_USD":-72827000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":6668000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":11432000.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-1.57,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.93,"CommonStockValue_0_Q2_USD":6000.0,"CommonStockSharesOutstanding_0_Q2_shares":58940933.0,"CommonStockSharesIssued_0_Q2_shares":58940933.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":285185000.0,"AssetsCurrent_0_Q2_USD":471599000.0,"Assets_0_Q2_USD":481389000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":9429282.0,"AdditionalPaidInCapital_0_Q2_USD":706713000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":144000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":18440000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":3500000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":8264000.0,"StockholdersEquity_0_Q2_USD":428710000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q2_USD":326246000.0,"OtherAssetsNoncurrent_0_Q2_USD":1323000.0,"OperatingLeasesFutureMinimumPaymentsDue_0_Q2_USD":10100000.0,"NonoperatingIncomeExpense_2_Q2_USD":948000.0,"NonoperatingIncomeExpense_1_Q2_USD":301000.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":110000.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":437000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":1751000.0,"ShareBasedCompensation_2_Q2_USD":7932000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":58835000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":35693000.0,"PreferredStockValue_0_Q2_USD":0.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-278153000.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"PreferredStockSharesAuthorized_0_Q2_shares":10000000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"OperatingIncomeLoss_2_Q2_USD":-73775000.0,"OperatingIncomeLoss_1_Q2_USD":-45375000.0,"OperatingExpenses_2_Q2_USD":77275000.0,"OperatingExpenses_1_Q2_USD":47125000.0,"DepreciationAndAmortization_2_Q2_USD":1629000.0,"CommonStockSharesAuthorized_0_Q2_shares":400000000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"AccruedLiabilitiesCurrent_0_Q2_USD":5611000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":46419724.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":48556843.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q2_USD":607000.0,"Ticker":"RCUS","CIK":"1724521","name":"ARCUS BIOSCIENCES, INC.","OfficialName":"Arcus Biosciences Inc. Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"2226368293.0","Country":"nan","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"nan","filed":"20200806"}]